Alterity Therapeutics Limited announced a General Meeting on May 29, 2026, to vote on director elections, a 50:1 share consolidation, director-related option issuances, constitution amendment, and incentive plan securities.
Key takeaways
General Meeting scheduled online for Friday, May 29, 2026 at 12pm AEST.
Resolution 1: Election of Mr Julian Babarczy, casually appointed November 21, 2025.
Resolution 2: Election of Ms Ann Cunningham, appointed April 17, 2026.
Resolution 3: Approve 50:1 consolidation of shares and options, fractions rounded up.
Resolution 4: Issue up to 100M pre-consolidation Options to Mr Julian Babarczy.
Resolution 6: Special resolution to amend Constitution for 10% employee plan issue cap.